Loading…
Recovering Fraudulent Claims Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Recovering Fraudulent Claims Act This bill requires the Department of Justice to establish the COVID-19 Unemployment Insurance Fraud Task Force. The task force must investigate fraud related to COVID-19 unemployment insurance benefits, including fraud involving identity theft. The Government Accountability Office must study COVID-19 unemployment insurance fraud, including whether available funds are being utilized or underutilized by states to prevent fraud and recover fraudulent payments.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2022 · fourth_quarter · Health Issues
Mental Health issues (incl. mental health parity, impacts of COVID-19 on TS and co-occurring conditions, suicide prevention,) General Health Care issues (preexisting coverage, medicare/medicaid) Medicare Part D Protected Class Drugs Coverage Research, Medical and Scientific Issues (including BRAIN initiative) Access to Treatment and Care Issues (including step therapy, prior authorization, non-medical switching including S464/HR2163 Safe Step Act) FDA Neuroscience Center of Excellence - BRAIN Act (HR5435) Drug Pricing Broadly CARE for TS Act (S2027/HR3679) Telehealth (need for coverage broad Agency designation) CONNECT for Health Act -S.2742/HR4932, Protection Post-COVID 19 Access to Telehealth Act - HR 366, Telehealth Modernization Act - S.368/HR1332 Collaborative Academic Research Efforts for Tourette Syndrome Act (S.2027/HR3679) Prior Authorization - Ensuring Seniors Timely Access to Care (HR3173) Build Back Better Inflation Reduction Act (HR 5326) Consolidated Appropriation Act (HR2617)
Read twice and referred to the Committee on Finance. (text: CR S6502-6503)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $40,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · third_quarter · Health Issues
Mental Health issues (incl. mental health parity, impacts of COVID-19 on TS and co-occurring conditions, suicide prevention) General Health Care issues (preexisting coverage, medicare/medicaid) Medicare Part D Protected Class Drugs Coverage Research, Medical and Scientific Issues (including BRAIN initiative) Access to Treatment and Care Issues (including step therapy, prior authorization, non-medical switching including S464/HR2163 Safe Step Act) FDA Neuroscience Center of Excellence - BRAIN Act (HR5435) Drug Pricing Broadly CARE for TS Act (S2027/HR3679) Telehealth (need for coverage broad Agency designation) CONNECT for Health Act -S.2742/HR4932, Protection Post-COVID 19 Access to Telehealth Act - HR 366, Telehealth Modernization Act - S.368/HR1332 Collaborative Academic Research Efforts for Tourette Syndrome Act (S.2027/HR3679) Prior Authorization - Ensuring Seniors Timely Access to Care (HR3173) Build Back Better Inflation Reduction Act
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · second_quarter · Health Issues
Mental Health issues (incl. mental health parity, impacts of COVID-19 on TS and co-occurring conditions, suicide prevention) General Health Care issues (preexisting coverage, medicare/medicaid) Medicare Part D Protected Class Drugs Coverage Research, Medical and Scientific Issues (including BRAIN initiative) Access to Treatment and Care Issues (including step therapy, prior authorization, non-medical switching including S464/HR2163 Safe Step Act) FDA Neuroscience Center of Excellence - BRAIN Act (HR5435) Drug Pricing Broadly CARE for TS Act (S2027/HR3679) Telehealth (need for coverage broad Agency designation) CONNECT for Health Act -S.2742/HR4932, Protection Post-COVID 19 Access to Telehealth Act - HR 366, Telehealth Modernization Act - S.368/HR1332 Collaborative Academic Research Efforts for Tourette Syndrome Act (S.2027/HR3679) Prior Authorization - Ensuring Seniors Timely Access to Care (HR3173)
Client expense: $40,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · first_quarter · Health Issues
Mental Health issues (incl. mental health parity, impacts of COVID-19 on TS and co-occurring conditions, suicide prevention) General Health Care issues (preexisting coverage, medicare/medicaid) Medicare Part D Protected Class Drugs Coverage Research, Medical and Scientific Issues (including BRAIN initiative) Access to Treatment and Care Issues (including step therapy, prior authorization, non-medical switching including S464/HR2163 Safe Step Act) FDA Neuroscience Center of Excellence - BRAIN Act (HR5435) Drug Pricing Broadly CARE for TS Act (S2027/HR3679) Telehealth (need for coverage broad Agency designation) CONNECT for Health Act -S.2742/HR4932, Protection Post-COVID 19 Access to Telehealth Act - HR 366, Telehealth Modernization Act - S.368/HR1332 Collaborative Academic Research Efforts for Tourette Syndrome Act (S.2027/HR3679) Prior Authorization - Ensuring Seniors Timely Access to Care (HR3173)
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2021 · fourth_quarter · Health Issues
Mental Health issues (incl. mental health parity, impacts of COVID-19 on TS and co-occurring conditions, suicide prevention) General Health Care issues (preexisting coverage, medicare/medicaid) Medicare Part D Protected Class Drugs Coverage Research, Medical and Scientific Issues (including BRAIN initiative) Access to Treatment and Care Issues (including step therapy, prior authorization, non-medical switching including S464/HR2163 Safe Step Act) FDA Neuroscience Center of Excellence - BRAIN Act (HR5435) Drug Pricing Broadly CARE for TS Act (S2027/HR3679) Telehealth (need for coverage broad Agency designation) CONNECT for Health Act -S.2742/HR4932, Protection Post-COVID 19 Access to Telehealth Act - HR 366, Telehealth Modernization Act - S.368/HR1332 Collaborative Academic Research Efforts for Tourette Syndrome Act (S.2027/HR3679) Prior Authorization - Ensuring Seniors Timely Access to Care (HR3173)
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Education, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2021 · third_quarter · Health Issues
Mental Health issues (incl. mental health parity, impacts of COVID-19 on TS and co-occurring conditions, suicide prevention) General Health Care issues (preexisting coverage, medicare/medicaid) Medicare Part D Protected Class Drugs Coverage Research, Medical and Scientific Issues (including BRAIN initiative) Access to Treatment and Care Issues (including step therapy, prior authorization, non-medical switching including S464/HR2163 Safe Step Act) FDA Neuroscience Center of Excellence - BRAIN Act (HR5435) Drug Pricing Broadly CARE for TS Act (S2027/HR3679) Telehealth (need for coverage broad Agency designation) CONNECT for Health Act -S.2742/HR4932, Protection Post-COVID 19 Access to Telehealth Act - HR 366, Telehealth Modernization Act - S.368/HR1332 Collaborative Academic Research Efforts for Tourette Syndrome Act (S.2027/HR3679) Prior Authorization - Ensuring Seniors Timely Access to Care (HR3173)
Client expense: $40,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Education, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2021 · second_quarter · Health Issues
Mental Health issues (incl. mental health parity, impacts of COVID-19 on TS and co-occurring conditions, suicide prevention) General Health Care issues (preexisting coverage, medicare/medicaid) Medicare Part D Protected Class Drugs Coverage Research, Medical and Scientific Issues (including BRAIN initiative) Access to Treatment and Care Issues (including step therapy, prior authorization, non-medical switching including S464/HR2163 Safe Step Act) Drug Pricing Broadly CARE for TS Act (S Telehealth (need for coverage broadly including COVID-19 pandemic and need to continue emergency coverage after public health emergency designation) CONNECT for Health Act -S.2742/HR4932 Collaborative Academic Research Efforts for Tourette Syndrome Act (S.2027/HR3679)
Client expense: $40,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE